L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects.
D001714:Bipolar Disorder / Q000139:chemically induced; D001835:Body Weight; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood* / Q000378:metabolism / Q000627:therapeutic use*; D005215:Fasting; D006801:Humans; D009135:Muscular Diseases / Q000139:chemically induced; D009460:Neurologic Examination; D010300:Parkinson Disease / Q000188:drug therapy*; D011605:Psychoses, Substance-Induced / Q000209:etiology; D012893:Sleep Wake Disorders / Q000139:chemically induced; D013997:Time Factors
D004295:Dihydroxyphenylalanine